 |
|
|
| |
Effect of Baseline Resistance-Associated Variants on SVR With the 3D Regimen Plus RBV
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Christoph Sarrazin1, Mark S Sulkowski2, Preethi Krishnan3, Rakesh Tripathi3, Gretja Schnell3, Yan Xie3, Daniel E Cohen3, Roger Trinh3, Lino Rodrigues-Jr3, Yan Luo3, Nancy S Shulman3, Tami Pilot-Mati as3, Christi ne Collins3
1JW Goethe University Hospital, Frankfurt, Germany; 2Viral Hepati ti s Center, Johns Hopkins University, Balti more, Maryland, United States; 3AbbVie Inc., North Chicago, Illinois, United States
|
| |
|
|
|
|
|
